Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1711 results about "Hydrolase" patented technology

Hydrolase is a class of enzyme that commonly perform as biochemical catalysts that use water to break a chemical bond, which typically results in dividing a larger molecule to smaller molecules. Some common examples of hydrolase enzymes are esterases including lipases, phosphatases, glycosidases, peptidases, and nucleosidases.

Paenibacillus mucilaginosus FangSG101 and application thereof

The invention belongs to the technical field of microorganisms, and particularly relates to paenibacillus mucilaginosus FangSG101 and application thereof. The preservation number of the paenibacillus mucilaginosus FangSG101 is CCTCC NO: M 20232558, and the paenibacillus mucilaginosus FangSG101 can convert insoluble mineral potassium and mineral phosphorus in soil into quick-acting potassium which can be directly absorbed and utilized by plants, has the capability of generating pathogenic bacterium cell wall hydrolase, has a remarkable promotion effect on seed germination and plant growth of tomatoes and cucumbers, and can be applied to actual agricultural production. Through optimization of a culture medium formula and adjustment of a fermentation process, a bacterial powder product with high viable count and high spore rate is obtained.
Owner:漯河微康农业生物科技有限公司

Application of bifidobacterium animalis in anti-inflammation, anti-helicobacter pylori and improvement of obesity, hyperlipidemia and bone loss

PendingCN119570671Aslow down weight gainreduce weightAntibacterial agentsBacteriaDiseaseBile salt hydrolase
The invention discloses a strain of bifidobacterium animalis dipro-60 and a preparation method thereof. The invention further discloses a preparation, and the preparation contains the bifidobacterium animalis dipro-60. The bifidobacterium animalis dipro-60 used in the invention has the ability of producing bile salt hydrolase BSH, the ability of reducing cholesterol, the ability of inhibiting helicobacter pylori and the ability of reducing inflammatory factor TNF-alpha; further animal experiments show that the dipro-60 can improve lipid metabolism related diseases, can significantly reduce weight gain of obese mice induced by high fat, significantly reduce the liver weight of the obese mice, reduce the content of triglyceride and blood sugar in blood, improve intestinal barriers and improve the lipid metabolism related diseases, and the dipro-60 can improve the lipid metabolism related diseases. Liver lipid accumulation caused by obesity or hyperlipidemia is improved, and bone loss caused by obesity or hyperlipidemia is improved.
Owner:DIPROBIO (SHANGHAI) CO LTD

Recombinant escherichia coli for producing D-mannose and preparation method thereof

The invention discloses recombinant escherichia coli for producing D-mannose and a preparation method of the recombinant escherichia coli, and belongs to the field of food chemical industry. The invention provides a recombinant bacterium. The recombinant bacterium is obtained by modifying escherichia coli in the following A) and B), a) inhibiting or reducing the expression of a pfkA gene, a pfkB gene, a zwf gene and / or an lpxM gene in the escherichia coli; and B) improving the expression of the encoding gene of the D-mannose 6-phosphate isomerase, the encoding gene of the phosphomannose mutase, the encoding gene of the phosphomannose guanylate transferase and the encoding gene of the GDP-mannose hydrolase in the escherichia coli. The recombinant strain provided by the invention takes D-glucose, glycerol and the like as carbon sources for microbial growth, and also can grow by using a mixed carbon source containing the carbon source components. And after microorganisms grow to a certain biomass, D-mannose is synthesized by taking D-glucose as a raw material.
Owner:MICROCYTO BIOTECHNOLOGY (BEIJING) CO LTD

Saccharomyces cerevisiae strain for efficiently synthesizing cordycepin as well as construction method and application thereof

The invention relates to a saccharomyces cerevisiae strain for efficiently synthesizing cordycepin as well as a construction method and application of the saccharomyces cerevisiae strain, and belongs to the technical field of microbial genetic engineering. The construction method provided by the invention comprises the following steps: carrying out multi-copy genome integrated expression on heterologous codon optimized 2 '-carbonyl-3'-deoxyadenosine reductase genes and 3 '-adenosine monophosphate phosphohydrolase genes, so as to increase the dosage of key enzymes; and supplementing the defective gene of the engineering strain to obtain the saccharomyces cerevisiae strain B5U3 with high yield of cordycepin. According to the obtained saccharomyces cerevisiae strain for efficiently synthesizing the cordycepin, the cordycepin yield reaches 2.92 g / L after shake flask fermentation, the cordycepin yield reaches 7.5 g / L after fermentation in a fermentation tank, and a foundation is laid for safer and more reliable industrial production of the cordycepin.
Owner:NANJING TECH UNIV

High-activity high-thermal-stability MHET hydrolase mutant and application thereof

The invention discloses a high-activity and high-thermal-stability MHET hydrolase mutant and application thereof. The invention provides a mutant protein of thermophilic carboxylesterase, which is shown as 1) or 2): 1) the protein shown as 1) is a protein obtained by mutating amino acid residues at the 130th site and the 171th site of wild thermophilic carboxylesterase shown as SEQ ID NO.2 or a sequence corresponding to the SEQ ID NO.2 and keeping other amino acid residues unchanged; (2) the protein is obtained by mutating amino acid residues at the 127th site, the 130th site and the 171th site of wild thermophilic carboxylesterase and keeping other amino acid residues unchanged. Experiments prove that the activity of the modified mutant for catalyzing MHET hydrolysis at the temperature of 50 DEG C is improved by 95 times compared with that of a wild type, and the modified mutant has higher enzyme activity and thermal stability and is the first enzyme capable of efficiently catalyzing MHET hydrolysis at the temperature of 50 DEG C at present.
Owner:BEIJING UNIV OF CHEM TECH

Modified artificial'two-step 'terpenoid production way and high-yield rimane type terpenoid by using escherichia coli

The invention discloses a modified artificial'two-step 'terpene production way and high-yield rimane type terpenoids by using escherichia coli, hydrolase and drimenol synthase are subjected to fusion expression for the first time, and the yield is increased by 7.3 times. The phosphorylation efficiency is further improved by 3.6 times by combining a two-step method path PhoN with rational design, finally, the yield of drimenol is improved by 27 times by optimizing fermentation conditions and is improved to 398.4 mg / L from 15 mg / L, a high-yield system is successfully migrated to production of albicanol, and the yield of 3.5 g / L is obtained.
Owner:CHINA PHARM UNIV

Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1

Disclosed herein are methods that aid in the diagnosis and evaluation of a human subject that has sustained or may have sustained an injury to the head, such as mild or moderate to severe traumatic brain injury (TBI), using an early biomarker, ubiquitin carboxy-terminal hydrolase L1 (UCH-L1). Also disclosed here are methods that aid in determining whether a human subject that has sustained an injury or may have sustained to the head would benefit from and thus receive a head computerized tomography (CT) scan based on the levels of UCH-L1. These methods involve detecting levels and changes in levels of UCH-L1 in one or more samples taken from a human subject at time points within 24 hours after the subject has sustained or may have sustained an injury to the head.
Owner:ABBOTT LAB INC

Method for efficiently synthesizing D-psicose from escherichia coli by using nutritional sweetener-cane sugar

The invention relates to the field of metabolic engineering, and provides a method for efficiently synthesizing D-psicose from escherichia coli by using a nutritional sweetening agent-cane sugar, the D-psicose is produced by using the cheap traditional nutritional sweetening agent through recombinant escherichia coli, and the D-psicose is produced by using escherichia coli JM109 (DE3) as a chassis host. According to the method, foreign proteins including sucrose-6-phosphohydrolase CscA, sucrose permease CscB, fructokinase CscK, D-psicose-6-phosphate epimerase Al sE and D-psicose-6-phosphate phosphatase A6PP are introduced into wild type escherichia coli to realize co-expression, and a path for producing D-allose from sucrose is constructed. By introducing ptsG-F and knocking out ptsG, fruA, pts I and ptsH, a sugar transmembrane transport pathway is re-planned, so that the utilization rate of a substrate is increased.
Owner:QINGYUAN INNOVATION LABORATORY

Culture medium and method for culturing Ackermania muciniphila for activating Amuc-1260 by using lambda-carrageenan as carbon source

The invention relates to the technical field of microorganisms, in particular to a culture medium and a method for culturing Ackermania muciniphila for activating Amuc-1260 by using lambda-carrageenan as a carbon source, according to the culture method, the lambda-carrageenan is used for replacing a traditional carbon source, thallus growth and proliferation can be remarkably promoted, the effect is optimal under the condition of 2.00 g / L, and the culture cost is low. Compared with the conventional carbon source (glucose), the carbon source is improved by 92.91%. Further research finds that the lambda-carrageenan can induce the Akk bacteria to up-regulate the expression of glycoside hydrolase such as Amuc-1260 and enhance the activity of pathways such as glycosaminoglycan degradation, amino acid metabolism and insulin signals, so that the metabolic adaptability and energy utilization efficiency of the bacteria are improved. Meanwhile, the Akk bacteria secrete more functional short-chain fatty acids such as acetic acid, propionic acid and the like under the condition, and have the effects of regulating intestinal health and maintaining metabolic homeostasis. The invention provides a new theoretical basis and technical support for large-scale culture of Akk bacteria and development of a metabiotic product.
Owner:JIMEI UNIV

Method for improving cordycepin synthesized by saccharomyces cerevisiae and saccharomyces cerevisiae engineering bacteria

The invention relates to the technical field of microbial genetic engineering, in particular to a method for improving cordycepin synthesized by saccharomyces cerevisiae and saccharomyces cerevisiae engineering bacteria. According to the invention, codon-optimized 2 '-carbonyl-3'-deoxyadenosine reductase gene and 3 '-adenosine monophosphate phosphohydrolase gene from cordyceps militaris are expressed by using plasmids, and then the plasmids are transformed into host cells to obtain the saccharomyces cerevisiae engineering bacteria. And inoculating a seed solution obtained by seed culture of the activated saccharomyces cerevisiae engineering bacteria into a fermentation culture medium containing a metabolic effector, and carrying out fermentation culture to synthesize cordycepin. Metabolic effectors (Cu < 2 + >, Fe < 2 + >, Mg < 2 + >, Zn < 2 + >, citric acid, cysteine, aspartic acid, glycine, VB1 and tea polyphenol) are added into a fermentation culture medium strain, and the variety and concentration of the metabolic effectors are optimized, so that the yield and synthesis efficiency of cordycepin are remarkably improved. By using the combination of the strain obtained by the invention and the optimal effector, the yield of cordycepin in a fermentation tank reaches 2.9 g / L.
Owner:NANJING TECH UNIV

PARG inhibitor

Provided in the present disclosure are certain compounds for inhibiting the activity of Poly ADP-Ribose Glycohydrolase (PARG). The present disclosure also relates to a method for preparing these compounds, a pharmaceutical composition comprising same, and the use thereof in the treatment of cancers and other diseases. The compounds have the structure as shown in formula (IA).
Owner:SHANGHAI QILU PHARMACEUTICAL RESEARCH & DEVELOPMENT CENTRE LTD

Carbamoylase mutant

The invention discloses a carbamoylase mutant SEQ ID NO: 3, which can efficiently catalyze the hydrolysis of N-carbamoyl-D-p-hydroxyphenylglycine to D-p-hydroxyphenylglycine, has high thermal stability, and can be used for industrial dual-enzyme method to catalyze the generation of D-p-hydroxyphenylglycine.
Owner:SHANGHAI BANGLIN BIOTECHNOLOGY CO LTD

Ethyl carbamate-reduced Caribike Yarrowia spp. And application of Caribike Yarrowia spp.

The invention relates to the field of microbial fermentation, in particular to an ethyl carbamate-reducing Caribik Yarrowia spp. And application of the Caribik Yarrowia spp. The invention discloses Meyerozyma caribba P3, the enzyme activity of ethyl carbamate hydrolase of the Meyerozyma caribba P3 is high and can reach 980.40 U, and when the Meyerozyma caribba P3 is applied to yellow wine fermentation, 49.5% of yellow wine EC can be degraded. The yeast strain for degrading the ethyl carbamate in the fermented food has the advantages of being high in fermentation capacity, capable of tolerating low-acid, high-sugar and 12% alcohol environments and the like, and a valuable strain source is provided for degrading the ethyl carbamate in the fermented food through a microbiological method.
Owner:HUNAN AGRI UNIV +1

Preparation method of protein beverage

The invention provides a preparation method of a protein base material for preparing a protein beverage, which comprises the following steps: adding yeast protein or yeast powder into a liquid, and dispersing and hydrating to form a suspension; adding an enzyme into the suspension for enzymolysis; wherein the enzyme comprises a first enzyme, a second enzyme and a third enzyme; the first enzyme and the second enzyme are protease, and the third enzyme is cellulose hydrolase. According to the method, the solubility and flavor of the yeast protein can be effectively improved, and the yeast protein beverage with excellent flavor and stability is finally obtained. The yeast protein beverage base material which is good in flavor, high in solubility, less in additive and easier to digest and absorb can be prepared through physical and enzymolysis methods which are easy to realize in the food industry without adding other substances.
Owner:BEIJING EVOLYZER CO LTD

High-activity PET hydrolase mutant and application thereof

The invention belongs to the field of biological catalysis, and discloses a high-activity PET hydrolase mutant and application thereof. The mutant of the thermophilic PET hydrolase provided by the invention is as shown in 1), 2) or 3): 1) a protein corresponding to an amino acid sequence SEQ ID NO.4; 2) a protein corresponding to the amino acid sequence of SEQ ID NO.6; and 3) a protein corresponding to the amino acid sequence of SEQ ID NO.8. Experiments prove that the modified mutant shows higher catalytic efficiency on PET hydrolysis and can keep activity for a long time at the optimal temperature for PET depolymerization. The activity of the mutant protein BhrM3 for catalyzing PET hydrolysis is improved by 1.82 times compared with that of a wild type and is 1.22 times that of efficient PET hydrolase LCC-ICCG, and the protein melting temperature reaches 92.9 DEG C.
Owner:BEIJING UNIV OF CHEM TECH

Burkholderia paradensis and application thereof

The invention discloses Burkholderia paradensis and application thereof, and relates to the technical field of microorganisms, the Burkholderia paradensis S3-22L provided by the invention is preserved in China General Microbiological Culture Collection Center (CGMCC), the strain preservation number is GGMCC NO: 31325, the preservation date is July 16, 2024, the preservation number is CGMCC NO: 31325, the preservation number is CGMCC NO: 31325, the preservation number is CGMCC NO: 31325, the preservation number is CGMCC NO: 31325, the preservation number is CGMCC NO: 31325, the preservation number is CGMCC NO: 31325, the preservation number is CGMCC NO: 31325, and the preservation number is CGMCC NO: 31325. The 16S rDNA (ribosomal deoxyribonucleic acid) sequence of the Burkholderia paradensis S3-22L is as shown in SEQ ID NO. 1; the strain obtained through screening can dissolve insoluble inorganic phosphorus and mineralize organic phosphorus, can also produce IAA and siderophore and secrete hydrolytic enzymes such as phosphatase, has an inhibition effect on growth and reproduction of ralstonia solanacearum, has an important application effect on prevention and treatment of plant bacterial wilt, and is harmless to the environment and human beings.
Owner:ZHEJIANG FORESTRY UNIVERSITY +1

Plastic hydrolase ThPETase mutant and application thereof

The invention belongs to the technical field of enzyme engineering, and particularly relates to a plastic hydrolase ThPETase mutant and application thereof, and the plastic hydrolase ThPETase mutant is obtained by mutating multiple sites in the 48th site, the 204th site, the 213th site, the 214th site and the 253rd site of an amino acid sequence as shown in SEQ ID NO.1. Molecular modification is carried out on the basis of wild type ThPETase, under the condition that the wild type ThPETase hardly has hydrolytic activity on PBAT, the mutant obtained by the invention has obvious hydrolytic ability on PBAT, a plastic film made of PBAT material can be hydrolyzed into powder at 37 DEG C within 2 weeks, and the yield of the plastic film is greatly improved. And compared with a wild type, the obtained mutant has the advantages that the thermal stability is greatly improved, and the industrial application prospect is huge.
Owner:XIANGHU LABORATORY

Group of amide hydrolase mutants capable of efficiently degrading ochratoxin A as well as encoding gene, recombinant vector and application of amide hydrolase mutants

The invention discloses a group of amide hydrolase mutants capable of efficiently degrading ochratoxin A as well as a coding gene, a recombinant vector and application of the amide hydrolase mutants, and belongs to the technical field of enzyme engineering. The invention also provides application of the mutant of the group of recombinant amide hydrolase in detoxification of ochratoxin A in beer or corn flour polluted by ochratoxin A. The activity of the mutant on ochratoxin A is obviously improved compared with the activity of the existing recombinant amide hydrolase ADH3; beer or corn flour containing ochratoxin A is treated for 10-15 minutes, the degradation rate of ochratoxin A can reach 100%, and the degradation efficiency is high in the field.
Owner:HUBEI UNIV

Bacillus velezensis, antibacterial lipopeptide and application thereof

The invention relates to the technical field of microorganism application, in particular to bacillus velezensis, antibacterial lipopeptide and application of the bacillus velezensis and the antibacterial lipopeptide. The invention provides bacillus velezensis BGMW2 separated from a mangrove forest water area in Qinzhou city in Guangxi Zhuang Autonomous District, and the preservation number of the bacillus velezensis BGMW2 is GDMCC No: 64790. The strain BGMW2 has broad-spectrum antibacterial activity, and can significantly inhibit pathogenic bacteria such as escherichia coli, salmonella typhimurium, shigella, bacillus licheniformis and staphylococcus aureus. According to the invention, an antibacterial lipopeptide is separated from a metabolite of the strain BGMW2, and the antibacterial lipopeptide is separated, purified and identified as C12surfactin. The antibacterial effect of the C12surfactin is superior to that of a common bacteriostatic agent Nisin, and can be comparable with that of gentamicin sulfate. The C12surfactin also has the characteristic of stable antibacterial property at the temperature of between 40 and 80 DEG C and the pH value of between 2.0 and 12.0, and has hydrolase resistance and low hemolytic activity. The bacterial strain BGMW2 and a metabolite antibacterial lipopeptide thereof provided by the invention have important application prospects in the fields of food, pharmacy, disinfection, protection, health care products, cosmetics and the like.
Owner:GUANGXI UNIV

Disulfiram derivatives as ALDH1a1 and MAGL inhibitors

ActiveUS12227469B2DiseaseAntagonism
A disulfiram derivative of formula (I)wherein R1 and R2 are independently —CH2CH2COOH, —CH2CH2COOEt, optionally substituted methylenepyridyl, optionally substituted methylenefuranyl, or optionally substituted methylenethiopenyl, may be useful in aldehyde dehydrogenase 1a1 (ALDH1a1) and / or monoacylglycerol lipase (MAGL)-mediated diseases or disorders. Such derivatives may avoid or limit aldehyde dehydrogenase 2 (ALDH2) and / or fatty acid amide hydrolase (FAAH) antagonism.
Owner:BATTERJEE MEDICAL COLLEGE

Uracil production strain as well as construction method and application thereof

The invention relates to the technical production field of metabolic engineering and genetic engineering, and particularly provides a uracil production strain as well as a construction method and application thereof. According to the strain, a uridine kinase gene udk is knocked out on an E.coli W3110 genome, and meanwhile, a T7RNA polymerase gene is integrated; the uridine monophosphate kinase gene pyrH is weakened; the method comprises the following steps: overexpressing a carbamyl phosphate synthetase gene carAB, a ribose phosphate pyrophosphate kinase gene prsA, a pyrimidine-5 '-nucleoside enzyme gene ppnN, UMP phosphohydrolase genes umpH and umpG, a ribonucleoside hydrolase 1 gene rihA and a glutamine synthetase gene glnA; an orotic acid nucleoside monophosphate decarboxylase gene pyrF and an orotic acid ribosyltransferase gene pyrE of wild type bacillus subtilis B.subtilis 168 are introduced in a heterologous manner, so that an orotate nucleoside monophosphate decarboxylase gene pyrF and an orotate ribosyltransferase gene pyrE are obtained. The safe, efficient and low-cost production of the uracil is realized.
Owner:新疆瑞诺生物科技有限公司

Methanophilic genetically engineered bacterium for producing trehalose as well as construction method and application of methanophilic genetically engineered bacterium

The invention discloses a methanophilic genetically engineered bacterium for producing trehalose as well as a construction method and application of the methanophilic genetically engineered bacterium, and belongs to the technical field of industrial biology. The methanophilic genetically engineered bacterium capable of producing the trehalose is obtained by taking methanophilic bacteria methanophilic 5GB1, Alkalicicus glycogenes WONF2802 or methanophilic bacteria NG09 as host bacteria, introducing maltooligosyl trehalose synthase (MTS) into the host bacteria, and carrying out over-expression on maltooligosyl trehalose hydrolase (MTH), so as to obtain the methanophilic genetically engineered bacterium capable of producing the trehalose. Under the condition that methane or methanol serves as a carbon source, the yield of the produced trehalose can reach the gram level or above, a new low-carbon biosynthesis way can be provided for commercial production of the trehalose, and the methanophilic genetically engineered bacterium for producing the trehalose has a good industrial application prospect.
Owner:XI AN JIAOTONG UNIV

Silkworm chrysalis protein immunomodulatory peptide with high immunocompetence as well as preparation method and application thereof

The invention belongs to the technical field of biology, and particularly relates to silkworm chrysalis protein immunomodulatory peptide with high immunocompetence and a preparation method and application of the silkworm chrysalis protein immunomodulatory peptide. The invention provides a silkworm pupa protein immunomodulatory peptide. The amino acid sequence of the silkworm pupa protein immunomodulatory peptide is shown as SEQ ID NO. 2, SEQ ID NO. 3 and / or SEQ ID NO. 8. The silkworm chrysalis protein immunomodulatory peptide is prepared by the following steps: hydrolyzing silkworm chrysalis protein by adopting alkaline protease, and separating and purifying an enzymolysis product by ultrafiltration and gel filtration; a peptide fragment with the strongest immunocompetence is screened by measuring an immunocompetence index, and the silkworm pupa protein immunomodulatory peptide with the high immunocompetence is obtained through LC-MS / MS identification. The immunomodulatory peptide is strongly combined with TLR2 and TLR4 / MD-2 receptors through hydrogen bonds and hydrophobic force to activate immunity, and both the immunomodulatory peptide and the TLR2 and the TLR4 / MD-2 receptors can effectively promote proliferation and phagocytosis of macrophages. The immunocompetence peptide has good immunocompetence and can be used as a potential functional food raw material.
Owner:金凤实验室

Ochratoxin A degrading enzyme mutant and application thereof

The invention discloses an ochratoxin A degrading enzyme mutant and application thereof. The invention provides mutant protein of amidase MiADH, which is any one of the following changes: the amino acid sequence of the amidase MiADH as shown in SEQ ID NO: 1 is subjected to any one of the following changes: a 66th amino acid residue Y is mutated into K, or a 143rd amino acid residue H is mutated into A, or a 194th amino acid residue V is mutated into A, or a 195th amino acid residue L is mutated into A, or a 230th amino acid residue H is mutated into A, or the amino acid sequence of the amidase MiADH is mutated into A, or the amino acid sequence of the amidase MiADH is mutated into K, or the amino acid sequence of the amidase MiADH is mutated into A; or the 324th amino acid residue V is mutated into A, and the protein has the same function; experiments prove that the amide hydrolase MiADH mutant can efficiently degrade OTA, and OTA detoxification can be achieved under the high-temperature condition.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

Solid composite carbon source for sewage denitrification and application thereof

The invention discloses a solid composite carbon source for sewage denitrification and a preparation method thereof. The composite carbon source is prepared from the following components in parts by weight: 10 to 60 parts of sodium acetate, 10 to 30 parts of glucose, 10 to 30 parts of starch, 0.1 to 2 parts of yeast powder, 1 to 5 parts of cellulose and 0.1 to 0.3 part of glycosyl hydrolase. Sodium acetate in the composite carbon source can react quickly, an instantaneous carbon source is provided, glucose and starch can be utilized by microorganisms for a long time, and durability of the carbon source is guaranteed. The invention also provides a sewage treatment method using the composite carbon source, and the method comprises the following steps: adding the composite carbon source into sewage, and carrying out denitrification treatment. The addition amount of the composite carbon source is determined based on the C / N ratio in the sewage. By adding the composite carbon source, the content of nitrate nitrogen in sewage can be effectively reduced, so that the sewage treatment efficiency is improved. The composite carbon source exists in a solid form, is convenient to store and transport, and reduces the influence on the environment. The composite carbon source not only can obviously improve the sewage treatment effect and improve the effluent quality, but also can reduce the operation cost and additional cost, and has important significance for improving the environment.
Owner:齐光耀

Deep sea-derived pet hydrolase dspetase05 and use thereof

PCT designated stage expiredWO2025007436A1HydrolasesWater contaminantsNucleotideNucleotide sequencing
The present invention relates to a deep sea-derived PET hydrolase and the use thereof. Provided is a deep sea-derived PET hydrolase dsPETase05, which has an amino acid sequence as shown in SEQ ID NO. 1. Further provided is a gene encoding the PET hydrolytic enzyme dsPETase05, which gene has a nucleotide sequence as shown in SEQ ID NO. 2. The PET hydrolase dsPETase05 can exhibit a high hydrolytic activity against PET in a high-salt or high-temperature environment.
Owner:SHANDONG UNIV +1

Tea leaf watering device

The invention relates to the technical field of tea watering, and discloses a tea watering device which comprises a processing box, the back of the processing box is fixedly connected with a water tank, the top of the water tank is communicated with a plurality of spray pipes, the spray pipes extend into the processing box, and inverted-T-shaped sliding grooves are formed in the left side and the right side of the processing box respectively. Reciprocating swinging of a rectangular shaft can drive a spraying pipe to swing, reciprocating swinging of a spraying head can expand the spraying coverage range, water is more evenly distributed on the surfaces of tea leaves, left-right movement of a moving sleeve can drive the spraying pipe to move left and right, and therefore the spraying range of the tea leaves is widened, and the tea leaves can make full contact with the water; after the tea leaves are in full contact with water, hydrolase can be activated by full contact with the water, macromolecular substances such as protein and polysaccharide in the tea leaves can be decomposed into micromolecular substances such as amino acid and monosaccharide by the hydrolase, and the taste and aroma components of the tea leaves are increased.
Owner:ENSHI EXTREME LEAF TEA IND CO LTD

PET hydrolase mutant as well as preparation method and application thereof

The invention discloses a PET hydrolase mutant as well as a preparation method and application thereof, and belongs to the field of enzyme engineering. On the basis of FAST-PETase, in combination with deep learning prediction and enzyme engineering optimization strategies, a plurality of mutants with specific performance advantages are systematically constructed and screened, the method is suitable for application scenes with different temperatures, substrate loads and degradation efficiency requirements, and experimental basis and technical support are provided for constructing a diversified and combinable PET degrading enzyme system. The mutants show diversified advantages in different performance dimensions, for example, the enzyme activity of the K233R mutant is 1.62 times that of FAST-PETase, and the K233R mutant still keeps good thermal stability (1.03 times) after being subjected to heat treatment for 2 hours at the temperature of 50 DEG C; q224K is more remarkably improved in the aspect of thermal stability, and the residual activity after heat treatment is 1.64 times that of FAST-PETase.
Owner:SOUTH CHINA UNIV OF TECH

Recombinant pichia pastoris genetically engineered bacterium for expressing recombinant full-chain-length humanized collagen as well as preparation method and application of recombinant pichia pastoris genetically engineered bacterium

The invention relates to a recombinant pichia pastoris genetically engineered bacterium for expressing recombinant full-chain-length humanized collagen as well as a preparation method and application of the recombinant pichia pastoris genetically engineered bacterium, and belongs to the technical field of genetic engineering. The recombinant pichia pastoris genetically engineered bacterium disclosed by the invention expresses recombinant full-chain-length humanized collagen, and a ku70 gene of the recombinant pichia pastoris genetically engineered bacterium is knocked out and knocked into a recombinant 4-proline hydroxylase encoding gene. Recombinant full-chain-length humanized collagen is optimized, a 4-proline hydroxylase gene and a collagen gene are co-expressed in pichia pastoris to obtain hydroxylation modified recombinant collagen, and a corresponding recombinant pichia pastoris genetically engineered bacterium is provided, has proteolytic enzyme A defect and hydroxylation modification capability, and can be used for preparing a recombinant collagen product. The stability of the collagen in the fermentation process is improved. The recombinant full-chain-length humanized collagen provided by the invention is 100% homologous with III-type collagen derived from a human body, so that the immune risk is extremely low, and the biological activity is more perfect.
Owner:GUANGZHOU TRAUER BIOTECH